Robert Brown

31.8k total citations · 1 hit paper
504 papers, 18.5k citations indexed

About

Robert Brown is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Robert Brown has authored 504 papers receiving a total of 18.5k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Molecular Biology, 101 papers in Oncology and 76 papers in Cancer Research. Recurrent topics in Robert Brown's work include Epigenetics and DNA Methylation (74 papers), Cancer Genomics and Diagnostics (35 papers) and RNA modifications and cancer (29 papers). Robert Brown is often cited by papers focused on Epigenetics and DNA Methylation (74 papers), Cancer Genomics and Diagnostics (35 papers) and RNA modifications and cancer (29 papers). Robert Brown collaborates with scholars based in United States, United Kingdom and Canada. Robert Brown's co-authors include Gordon Strathdee, Jane A. Plumb, Frank Lyko, Stanley B. Kaye, James Paul, Jens M. Teodoridis, Peter R. Robichaud, P. Vasey, Alan Anthoney and Charlotte S. Wilhelm-Benartzi and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert Brown

473 papers receiving 17.9k citations

Hit Papers

Novel Molecular Subtypes of Serous and Endometrioid Ovari... 2008 2026 2014 2020 2008 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Brown United States 71 10.6k 4.5k 3.6k 1.9k 1.8k 504 18.5k
Akira Suzuki Japan 76 13.8k 1.3× 3.0k 0.7× 2.9k 0.8× 1.9k 1.0× 1.1k 0.6× 998 32.6k
Margaret A. Tucker United States 65 4.7k 0.4× 7.3k 1.6× 2.9k 0.8× 1.5k 0.8× 1.9k 1.0× 230 16.0k
Dan H. Moore United States 85 8.7k 0.8× 5.4k 1.2× 5.3k 1.5× 1.7k 0.9× 1.8k 1.0× 472 24.9k
J. Carl Barrett United States 69 10.7k 1.0× 6.8k 1.5× 5.3k 1.5× 4.6k 2.4× 1.7k 0.9× 313 21.2k
John D. Boice United States 74 2.4k 0.2× 4.3k 1.0× 2.8k 0.8× 3.7k 1.9× 2.1k 1.1× 324 20.6k
Daniel O. Stram United States 69 5.2k 0.5× 2.8k 0.6× 3.0k 0.8× 1.7k 0.9× 1.1k 0.6× 286 18.8k
Hong Li China 85 14.3k 1.4× 3.4k 0.8× 2.9k 0.8× 1.2k 0.6× 1.1k 0.6× 1.0k 29.7k
Shunichi Yamashita Japan 66 6.8k 0.6× 2.8k 0.6× 1.7k 0.5× 935 0.5× 853 0.5× 605 17.9k
Roy E. Shore United States 66 2.2k 0.2× 3.4k 0.8× 2.4k 0.7× 2.3k 1.2× 1.2k 0.7× 228 15.9k
Yongping Hao United States 19 6.3k 0.6× 7.1k 1.6× 3.2k 0.9× 5.0k 2.6× 1.6k 0.9× 28 18.2k

Countries citing papers authored by Robert Brown

Since Specialization
Citations

This map shows the geographic impact of Robert Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Brown more than expected).

Fields of papers citing papers by Robert Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Brown. The network helps show where Robert Brown may publish in the future.

Co-authorship network of co-authors of Robert Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Brown. A scholar is included among the top collaborators of Robert Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Brown. Robert Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curry, Edward, Constanze Zeller, Nahal Masrour, et al.. (2018). Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis. Cancer Research. 78(6). 1383–1391. 31 indexed citations
2.
Stronach, Euan A., James Paul, Kirsten M. Timms, et al.. (2018). Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy. Molecular Cancer Research. 16(7). 1103–1111. 81 indexed citations
3.
Broom, Bradley M., Michaël Ryan, Robert Brown, et al.. (2017). A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data. Cancer Research. 77(21). e23–e26. 26 indexed citations
4.
Borley, Jane, et al.. (2016). Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer. Clinical Cancer Research. 22(12). 3097–3104. 42 indexed citations
5.
Dennison, Jennifer B., Maria Shahmoradgoli, Wenbin Liu, et al.. (2016). High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype. Clinical Cancer Research. 22(20). 5068–5078. 26 indexed citations
6.
Flanagan, James M., Mark N. Brook, Nick Orr, et al.. (2014). Temporal Stability and Determinants of White Blood Cell DNA Methylation in the Breakthrough Generations Study. Cancer Epidemiology Biomarkers & Prevention. 24(1). 221–229. 47 indexed citations
7.
Zeller, Constanze, Wei Dai, Afshan Siddiq, et al.. (2013). Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors. Cancer Prevention Research. 6(12). 1348–1355. 23 indexed citations
8.
Dennison, Jennifer B., Jennifer R. Molina, Shreya Mitra, et al.. (2013). Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Cancer Research. 19(13). 3703–3713. 93 indexed citations
9.
Dai, Wei, Constanze Zeller, Nahal Masrour, et al.. (2013). Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 19(20). 5788–5797. 38 indexed citations
10.
Brennan, Kevin, Montserrat García‐Closas, Nick Orr, et al.. (2012). Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk. Cancer Research. 72(9). 2304–2313. 118 indexed citations
11.
Stronach, Euan A., Nona Rama, Christoph Datler, et al.. (2011). HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer. Cancer Research. 71(13). 4412–4422. 148 indexed citations
12.
Dai, Wei, Jens M. Teodoridis, Constanze Zeller, et al.. (2011). Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival. Clinical Cancer Research. 17(12). 4052–4062. 78 indexed citations
13.
Tothill, Richard W., Anna V. Tinker, Joshy George, et al.. (2008). Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome. Clinical Cancer Research. 14(16). 5198–5208. 1041 indexed citations breakdown →
14.
Strathdee, Gordon, Tessa L. Holyoake, Anton Parker, et al.. (2007). Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis. Clinical Cancer Research. 13(17). 5048–5055. 103 indexed citations
15.
Epping, Mirjam T., Liming Wang, Jane A. Plumb, et al.. (2007). A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors. Proceedings of the National Academy of Sciences. 104(45). 17777–17782. 65 indexed citations
16.
Wei, Susan, Curtis Balch, Henry Paik, et al.. (2006). Prognostic DNA Methylation Biomarkers in Ovarian Cancer. Clinical Cancer Research. 12(9). 2788–2794. 118 indexed citations
17.
Brown, Robert. (2002). HER-2/neu-Positive breast carcinoma: molecular concomitants by proteomic analysis and their therapeutic implications.. PubMed. 32(1). 12–21. 8 indexed citations
18.
Ayas, Najib, Robert Brown, & Steven A. Shea. (2000). Hypercapnia Can Induce Arousal from Sleep in the Absence of Altered Respiratory Mechanoreception. American Journal of Respiratory and Critical Care Medicine. 162(3). 1004–1008. 52 indexed citations
19.
Bloch‐Salisbury, Elisabeth, Christina M. Spengler, Robert Brown, & Robert B. Banzett. (1998). Self-Control and External Control of Mechanical Ventilation Give Equal Air Hunger Relief. American Journal of Respiratory and Critical Care Medicine. 157(2). 415–420. 28 indexed citations
20.
Keith, W. Nicol, Fiona Douglas, Gordon Wishart, et al.. (1993). Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20. European Journal of Cancer. 29(10). 1469–1475. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026